H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)

Go back to H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)
(NASDAQ: TRVI) Delayed: 17.26 +0.20 (1.17%)
Previous Close $17.06    52 Week High
Open $16.88    52 Week Low
Day High $17.32    P/E N/A 
Day Low $16.80    EPS
Volume 856,673